Literature DB >> 4191061

Don't use the wrong vitamin K.

J A Udall.   

Abstract

The emergency use of vitamin K is essentially limited to the reversal of drug-induced hypoprothrombinemia. In patients with adequate liver function, phytonadione acts promptly and predictably in this capacity whereas the derivatives of menadione counteract coumarin drugs only slightly or not at all. It is dangerous to rely on menadione analogues, and these drugs should be removed from emergency room drug stores.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4191061      PMCID: PMC1501329     

Source DB:  PubMed          Journal:  Calif Med        ISSN: 0008-1264


  6 in total

1.  Vitamin K1 in treatment of bishydroxycoumarin-induced hypoprothrombinemia; comparison of intravenous and intramuscular administration.

Authors:  M SHOSHKES; A J PERELMAN
Journal:  J Am Med Assoc       Date:  1956-07-21

2.  Clinical comparison of vitamin K1 and water-soluble vitamin K.

Authors:  J R GAMBLE; E W DENNIS; W W COON; P HODGSON; P W WILLS; J A MACRIS; I F DUFF
Journal:  AMA Arch Intern Med       Date:  1955-01

3.  Studies on the anticoagulant phenylindanedione. I. The effect of emulsified vitamin K1 on phenylindanedione-induced hypoprothrombinemia.

Authors:  C G GUTTAS; W C MOLONEY; H S SISE
Journal:  Blood       Date:  1953-03       Impact factor: 22.113

4.  The interrelationship of vitamin K and dicoumarin.

Authors:  G E COLLENTINE; A J QUICK
Journal:  Am J Med Sci       Date:  1951-07       Impact factor: 2.378

5.  Diphenylacetyl-1, 3-indandione as a potent hypoprothrombinemic agent.

Authors:  J T CORRELL; L L COLEMAN; S LONG; R F WILLY
Journal:  Proc Soc Exp Biol Med       Date:  1952-05

6.  Vitamin K and coumarin drug interrelationships in man.

Authors:  J A Udall
Journal:  Curr Ther Res Clin Exp       Date:  1966-12
  6 in total
  1 in total

Review 1.  Anaphylactoid reactions to vitamin K.

Authors:  L D Fiore; M A Scola; C E Cantillon; M T Brophy
Journal:  J Thromb Thrombolysis       Date:  2001-04       Impact factor: 2.300

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.